查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫學圖像分析軟件市場：按類型、按模式、按應用、按最終用戶：機會分析和行業預測，2022-2031 年
市場調查報告書
商品編碼
1266400

全球醫學圖像分析軟件市場：按類型、按模式、按應用、按最終用戶：機會分析和行業預測，2022-2031 年

Medical Image Analysis Software Market By Type, By Modality, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2022-2031
出版日期: | 出版商: Allied Market Research | 英文 220 Pages | 商品交期: 2-3個工作天內

價格

醫學圖像分析軟件市場在 2021 年價值 39 億美元，預計到 2031 年將達到 123 億美元，2022 年至 2031 年的複合年增長率為 12.2%。

醫學圖像分析軟件應用程序可以對許多模式的醫學圖像進行定量分析和可視化，例如 PET、MRI、CT 或顯微術。 支持手動和自動分析 3D 醫學圖像的應用程序為醫療保健提供者和患者帶來了廣泛的機會。 這包括促進早期診斷以提高治愈率和存活率的機器學習系統、用於驗證診斷的神經網絡，以及致力於發現隱藏模式和寶貴見解以改進藥物開發的研究。包含算法。 它還包括複雜圖像的檢查、精確定位治療區域並最大程度地減少侵入性手術過程中對健康組織的損害的不良症狀分割解決方案，以及針對醫療專業人員和患者的沉浸式培訓它還包括集成 3D 成像和虛擬現實 (VR) 設備的應用程序啟用教育，高級診斷。 通過將先進技術融入圖像解讀管道，醫療保健行業可以應對與大量數據相關的挑戰。 醫學圖像分析工具的定制軟件開發是這一過程中的關鍵步驟。

醫學圖像分析軟件市場的增長還受到慢性病發病率增加、老齡化社會對醫療服務需求增加以及計算機輔助診斷 (CAD) 等成像技術領域的持續開發的推動). 將被刪除。 此外，老年人口的增加和越來越多地採用能夠快速診斷慢性病的診斷超聲成像系統預計將對市場擴張做出重大貢獻。 此外，全球醫學圖像分析軟件市場的增長預計將在很大程度上受到醫學圖像分析軟件不斷進步等因素的推動，從而導致市場增長。 全球醫學圖像分析軟件市場的主要參與者正在投資於產品發布、收購、研發以推動醫學圖像分析軟件的進步，以加強他們的市場地位並保持競爭環境。我們正在選擇不同的策略，例如投資.

推動市場增長的主要因素包括對醫學圖像分析軟件產品優勢的認識顯著提高、軟件在醫學圖像分析中的使用率上升以及患病患者人數激增。它是 然而，存儲數據的安全風險以及高昂的安裝和維護成本阻礙了市場增長。 相反，人工智能 (AI) 在醫學成像中的引入正在改變預測期內的市場動態，預計這將為市場增長提供有利可圖的機會。 預計醫學成像領域的廣泛研發活動將為市場擴張開闢新途徑，同時顯著改善醫療基礎設施。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 頂級影響因子
    • 頂級投資基金
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭對手的實力
  • 市場動態
    • 司機
      • 慢性病患病率增加
      • 在圖像處理技術領域的發展日新月異
      • 增加在醫療領域的使用
    • 約束因素
      • 存儲數據的安全風險很高
    • 機會
      • 關於在醫學影像診斷中引入人工智能 (AI)
  • 分析 COVID-19 對市場的影響

第 4 章醫學圖像分析軟件市場：按類型

  • 概覽
    • 市場規模和預測
  • 整合
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 獨立的
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 5 章醫學圖像分析軟件市場：按模態分類

  • 概覽
    • 市場規模和預測
  • 計算機斷層掃描
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 磁共振成像
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 超聲波
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 多種方式
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 6 章醫學圖像分析軟件市場：按應用

  • 概覽
    • 市場規模和預測
  • 骨科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 牙科
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 神經學
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 心髒病學
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 腫瘤學
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 7 章醫學圖像分析軟件市場：按最終用戶分類

  • 概覽
    • 市場規模和預測
  • 醫院
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 診斷中心
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析
  • 其他
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場份額分析：國家/地區分析

第 8 章醫學圖像分析軟件市場：按地區

  • 概覽
    • 市場規模和預測：按地區
  • 北美
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按方式分類
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 美國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 加拿大
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 墨西哥
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
  • 歐洲
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按方式分類
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 德國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 法國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 英國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 意大利
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 西班牙
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 其他歐洲
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
  • 亞太地區
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按方式分類
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 中國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 日本
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模/預測：按方式
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 印度
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 澳大利亞
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 韓國
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 其他亞太地區
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
  • 拉美
    • 主要趨勢和機遇
    • 市場規模/預測：按類型
    • 市場規模和預測：按方式分類
    • 市場規模和預測：按應用
    • 市場規模和預測：按最終用戶分類
    • 市場規模/預測：按國家/地區分類
      • 巴西
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 沙特阿拉伯
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • 南非
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類
      • LAMEA 的其餘部分
      • 主要市場趨勢、增長動力和機遇
      • 市場規模/預測：按類型
      • 市場規模和預測：按方式分類
      • 市場規模和預測：按應用
      • 市場規模和預測：按最終用戶分類

第9章競爭格局

  • 介紹
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 定位頂級公司，2021 年

第十章公司簡介

  • Agfa Healthcare
  • CANON MEDICAL SYSTEMS CORPORATION
  • Coexya
  • ESAOTE SPA
  • GE Healthcare
  • IBM Corporation
  • Koninklijke Philips N.V.
  • MIM Software, Inc
  • Siemens Healthineers
  • Spacelabs Healthcare
Product Code: A11265

The medical image analysis software market was valued at $3.9 billion in 2021 and is projected to reach $12.3 billion by 2031, registering a CAGR of 12.2% from 2022 to 2031.  

The application of medical image analysis software enables quantitative analysis and visualization of medical images of numerous modalities such as PET, MRI, CT, or microscopy. The applications of enabling both manual and automated analysis of 3D medical images unlocks various opportunities to the benefit of providers and patients. It includes machine learning systems to facilitate early diagnostics for higher cure and survival rates, neural networks for diagnosis validation, research-specific algorithms to find hidden patterns and valuable insights to improve drug development. It may also include the examination of complex imaging types with adverse symptoms segmentation solutions to pinpoint a treatment area and thus minimizing possible damage to healthy tissue during an invasive procedure, applications integrating 3D imaging with virtual reality (VR) devices to enable immersive training of health specialists, patient education, and advanced diagnostics. Integrating advanced technologies into the image interpretation pipeline can help the healthcare sector address challenges associated with large amounts of data. Custom software development of medical image analysis tools is a critical step in this process. 

The growth of the medical image analysis software market is driven by increasing incidence of chronic diseases, rise in demand for health care services for the aging population, and continuous developments in the field of imaging technology, such as computer-aided diagnosis (CAD). Moreover, the rise in the geriatric population and growing adoption of ultrasound imaging systems to facilitate faster diagnosis of chronic diseases is expected to notably contribute toward the market growth. Furthermore, the global medical image analysis software market growth is largely driven by factors such as an increase in advancements of medical imaging software which is expected to lead to the growth of the market. Prominent players in the global medical image analysis software market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in medical image analysis software to strengthen their position in the market and sustain the competitive environment.  

A significant increase in awareness about the advantages of medical imaging software products, rise in the usage of software in medical imaging, and surge in the number of patients suffering from diseases are some of the key factors driving the growth of the market. However, the security risks of data stored concerns and high installation cost and maintenance hamper the market growth. Conversely, introduction of Artificial Intelligence (AI) in medical imaging has changed the market dynamics in the forecast period which is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical imaging along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market. 

The global medical image analysis software market is segmented based on type, modality, imaging type, application, end user, and region. On the basis of type, the market is classified into integrated and standalone. As per modalities, the market is classified into tomography, ultrasound imaging, radiographic imaging, and combined modalities. According to imaging type, the market is classified into 2D imaging, 3D imaging, and 4D imaging. Depending on application, the market is classified into orthopedic, dental, neurology, cardiology, oncology, obstetrics & gynecology, and others. By end user, the market is classified into hospitals, diagnostic centers, ambulatory surgical centers, and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major companies profiled in the report include: Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Spacelabs Healthcare, Agfa-Gevaert Group, MIM Software, Inc., Toshiba Medical Systems Corporation, ESAOTE SPA, Merge Healthcare, Inc., and Aquilab SAS. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the medical image analysis software market analysis from 2021 to 2031 to identify the prevailing medical image analysis software market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the medical image analysis software market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global medical image analysis software market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Integrated
  • Stand-alone

By Modality

  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Combined Modalities
  • Others

By Application

  • Orthopedic
  • Dental
  • Neurology
  • Cardiology
  • Oncology
  • Others

By End User

  • Hospitals
  • Diagnostic Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • IBM Corporation
  • CANON MEDICAL SYSTEMS CORPORATION
  • Siemens Healthineers
  • ESAOTE SPA 
  • Coexya
  • MIM Software, Inc
  • Koninklijke Philips N.V. 
  • GE Healthcare
  • Spacelabs Healthcare
  • Agfa Healthcare

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of chronic diseases
      • 3.4.1.2. Rise in developments in the field of imaging technology
      • 3.4.1.3. Increase in usage in medical applications
    • 3.4.2. Restraints
      • 3.4.2.1. High security risks of data stored
    • 3.4.3. Opportunities
      • 3.4.3.1. Introduction of Artificial Intelligence (AI) in medical imaging
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Integrated
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Stand-alone
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Computed Tomography
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Magnetic Resonance Imaging
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Ultrasound
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Combined Modalities
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country
  • 5.6. Others
    • 5.6.1. Key market trends, growth factors and opportunities
    • 5.6.2. Market size and forecast, by region
    • 5.6.3. Market share analysis by country

CHAPTER 6: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Orthopedic
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Dental
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Neurology
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Cardiology
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country
  • 6.6. Oncology
    • 6.6.1. Key market trends, growth factors and opportunities
    • 6.6.2. Market size and forecast, by region
    • 6.6.3. Market share analysis by country
  • 6.7. Others
    • 6.7.1. Key market trends, growth factors and opportunities
    • 6.7.2. Market size and forecast, by region
    • 6.7.3. Market share analysis by country

CHAPTER 7: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospitals
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Diagnostic Centers
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key trends and opportunities
    • 8.2.2. Market size and forecast, by Type
    • 8.2.3. Market size and forecast, by Modality
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Key market trends, growth factors and opportunities
      • 8.2.6.1.2. Market size and forecast, by Type
      • 8.2.6.1.3. Market size and forecast, by Modality
      • 8.2.6.1.4. Market size and forecast, by Application
      • 8.2.6.1.5. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Key market trends, growth factors and opportunities
      • 8.2.6.2.2. Market size and forecast, by Type
      • 8.2.6.2.3. Market size and forecast, by Modality
      • 8.2.6.2.4. Market size and forecast, by Application
      • 8.2.6.2.5. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Key market trends, growth factors and opportunities
      • 8.2.6.3.2. Market size and forecast, by Type
      • 8.2.6.3.3. Market size and forecast, by Modality
      • 8.2.6.3.4. Market size and forecast, by Application
      • 8.2.6.3.5. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key trends and opportunities
    • 8.3.2. Market size and forecast, by Type
    • 8.3.3. Market size and forecast, by Modality
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Key market trends, growth factors and opportunities
      • 8.3.6.1.2. Market size and forecast, by Type
      • 8.3.6.1.3. Market size and forecast, by Modality
      • 8.3.6.1.4. Market size and forecast, by Application
      • 8.3.6.1.5. Market size and forecast, by End User
      • 8.3.6.2. France
      • 8.3.6.2.1. Key market trends, growth factors and opportunities
      • 8.3.6.2.2. Market size and forecast, by Type
      • 8.3.6.2.3. Market size and forecast, by Modality
      • 8.3.6.2.4. Market size and forecast, by Application
      • 8.3.6.2.5. Market size and forecast, by End User
      • 8.3.6.3. UK
      • 8.3.6.3.1. Key market trends, growth factors and opportunities
      • 8.3.6.3.2. Market size and forecast, by Type
      • 8.3.6.3.3. Market size and forecast, by Modality
      • 8.3.6.3.4. Market size and forecast, by Application
      • 8.3.6.3.5. Market size and forecast, by End User
      • 8.3.6.4. Italy
      • 8.3.6.4.1. Key market trends, growth factors and opportunities
      • 8.3.6.4.2. Market size and forecast, by Type
      • 8.3.6.4.3. Market size and forecast, by Modality
      • 8.3.6.4.4. Market size and forecast, by Application
      • 8.3.6.4.5. Market size and forecast, by End User
      • 8.3.6.5. Spain
      • 8.3.6.5.1. Key market trends, growth factors and opportunities
      • 8.3.6.5.2. Market size and forecast, by Type
      • 8.3.6.5.3. Market size and forecast, by Modality
      • 8.3.6.5.4. Market size and forecast, by Application
      • 8.3.6.5.5. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Key market trends, growth factors and opportunities
      • 8.3.6.6.2. Market size and forecast, by Type
      • 8.3.6.6.3. Market size and forecast, by Modality
      • 8.3.6.6.4. Market size and forecast, by Application
      • 8.3.6.6.5. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key trends and opportunities
    • 8.4.2. Market size and forecast, by Type
    • 8.4.3. Market size and forecast, by Modality
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. China
      • 8.4.6.1.1. Key market trends, growth factors and opportunities
      • 8.4.6.1.2. Market size and forecast, by Type
      • 8.4.6.1.3. Market size and forecast, by Modality
      • 8.4.6.1.4. Market size and forecast, by Application
      • 8.4.6.1.5. Market size and forecast, by End User
      • 8.4.6.2. Japan
      • 8.4.6.2.1. Key market trends, growth factors and opportunities
      • 8.4.6.2.2. Market size and forecast, by Type
      • 8.4.6.2.3. Market size and forecast, by Modality
      • 8.4.6.2.4. Market size and forecast, by Application
      • 8.4.6.2.5. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Key market trends, growth factors and opportunities
      • 8.4.6.3.2. Market size and forecast, by Type
      • 8.4.6.3.3. Market size and forecast, by Modality
      • 8.4.6.3.4. Market size and forecast, by Application
      • 8.4.6.3.5. Market size and forecast, by End User
      • 8.4.6.4. Australia
      • 8.4.6.4.1. Key market trends, growth factors and opportunities
      • 8.4.6.4.2. Market size and forecast, by Type
      • 8.4.6.4.3. Market size and forecast, by Modality
      • 8.4.6.4.4. Market size and forecast, by Application
      • 8.4.6.4.5. Market size and forecast, by End User
      • 8.4.6.5. South Korea
      • 8.4.6.5.1. Key market trends, growth factors and opportunities
      • 8.4.6.5.2. Market size and forecast, by Type
      • 8.4.6.5.3. Market size and forecast, by Modality
      • 8.4.6.5.4. Market size and forecast, by Application
      • 8.4.6.5.5. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Key market trends, growth factors and opportunities
      • 8.4.6.6.2. Market size and forecast, by Type
      • 8.4.6.6.3. Market size and forecast, by Modality
      • 8.4.6.6.4. Market size and forecast, by Application
      • 8.4.6.6.5. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key trends and opportunities
    • 8.5.2. Market size and forecast, by Type
    • 8.5.3. Market size and forecast, by Modality
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Key market trends, growth factors and opportunities
      • 8.5.6.1.2. Market size and forecast, by Type
      • 8.5.6.1.3. Market size and forecast, by Modality
      • 8.5.6.1.4. Market size and forecast, by Application
      • 8.5.6.1.5. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Key market trends, growth factors and opportunities
      • 8.5.6.2.2. Market size and forecast, by Type
      • 8.5.6.2.3. Market size and forecast, by Modality
      • 8.5.6.2.4. Market size and forecast, by Application
      • 8.5.6.2.5. Market size and forecast, by End User
      • 8.5.6.3. South Africa
      • 8.5.6.3.1. Key market trends, growth factors and opportunities
      • 8.5.6.3.2. Market size and forecast, by Type
      • 8.5.6.3.3. Market size and forecast, by Modality
      • 8.5.6.3.4. Market size and forecast, by Application
      • 8.5.6.3.5. Market size and forecast, by End User
      • 8.5.6.4. Rest of LAMEA
      • 8.5.6.4.1. Key market trends, growth factors and opportunities
      • 8.5.6.4.2. Market size and forecast, by Type
      • 8.5.6.4.3. Market size and forecast, by Modality
      • 8.5.6.4.4. Market size and forecast, by Application
      • 8.5.6.4.5. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top player positioning, 2021

CHAPTER 10: COMPANY PROFILES

  • 10.1. Agfa Healthcare
    • 10.1.1. Company overview
    • 10.1.2. Key Executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. CANON MEDICAL SYSTEMS CORPORATION
    • 10.2.1. Company overview
    • 10.2.2. Key Executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Coexya
    • 10.3.1. Company overview
    • 10.3.2. Key Executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Key strategic moves and developments
  • 10.4. ESAOTE SPA 
    • 10.4.1. Company overview
    • 10.4.2. Key Executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
  • 10.5. GE Healthcare
    • 10.5.1. Company overview
    • 10.5.2. Key Executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
  • 10.6. IBM Corporation
    • 10.6.1. Company overview
    • 10.6.2. Key Executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
  • 10.7. Koninklijke Philips N.V. 
    • 10.7.1. Company overview
    • 10.7.2. Key Executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
  • 10.8. MIM Software, Inc
    • 10.8.1. Company overview
    • 10.8.2. Key Executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
  • 10.9. Siemens Healthineers
    • 10.9.1. Company overview
    • 10.9.2. Key Executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. Spacelabs Healthcare
    • 10.10.1. Company overview
    • 10.10.2. Key Executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio

LIST OF TABLES

  • TABLE 01. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 02. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 05. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 07. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 11. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 23. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 24. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 28. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 29. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 33. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 36. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 37. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 38. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 41. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 42. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 43. EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 44. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 45. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 46. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 49. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 50. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 53. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 54. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 55. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 57. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 58. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 59. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 60. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 62. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 64. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 65. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 66. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 67. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 68. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 69. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 70. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 71. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 73. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 74. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 75. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 77. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 79. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 81. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 82. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 83. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 84. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 85. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 86. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 87. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 88. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 89. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 91. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 94. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 97. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 101. LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 102. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 103. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 104. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 105. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 106. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 107. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 108. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 109. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 110. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 111. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 112. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 113. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 115. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021-2031 ($MILLION)
  • TABLE 116. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 117. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 118. AGFA HEALTHCARE: KEY EXECUTIVES
  • TABLE 119. AGFA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 120. AGFA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 121. AGFA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 122. AGFA HEALTHCARE: KEY STRATERGIES
  • TABLE 123. CANON MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 124. CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT SEGMENTS
  • TABLE 126. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127. CANON MEDICAL SYSTEMS CORPORATION: KEY STRATERGIES
  • TABLE 128. COEXYA: KEY EXECUTIVES
  • TABLE 129. COEXYA: COMPANY SNAPSHOT
  • TABLE 130. COEXYA: PRODUCT SEGMENTS
  • TABLE 131. COEXYA: PRODUCT PORTFOLIO
  • TABLE 132. COEXYA: KEY STRATERGIES
  • TABLE 133. ESAOTE SPA : KEY EXECUTIVES
  • TABLE 134. ESAOTE SPA : COMPANY SNAPSHOT
  • TABLE 135. ESAOTE SPA : PRODUCT SEGMENTS
  • TABLE 136. ESAOTE SPA : PRODUCT PORTFOLIO
  • TABLE 137. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 138. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 139. GE HEALTHCARE: SERVICE SEGMENTS
  • TABLE 140. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 141. IBM CORPORATION: KEY EXECUTIVES
  • TABLE 142. IBM CORPORATION: COMPANY SNAPSHOT
  • TABLE 143. IBM CORPORATION: SERVICE SEGMENTS
  • TABLE 144. IBM CORPORATION: PRODUCT PORTFOLIO
  • TABLE 145. KONINKLIJKE PHILIPS N.V. : KEY EXECUTIVES
  • TABLE 146. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT
  • TABLE 147. KONINKLIJKE PHILIPS N.V. : SERVICE SEGMENTS
  • TABLE 148. KONINKLIJKE PHILIPS N.V. : PRODUCT PORTFOLIO
  • TABLE 149. MIM SOFTWARE, INC: KEY EXECUTIVES
  • TABLE 150. MIM SOFTWARE, INC: COMPANY SNAPSHOT
  • TABLE 151. MIM SOFTWARE, INC: PRODUCT SEGMENTS
  • TABLE 152. MIM SOFTWARE, INC: PRODUCT PORTFOLIO
  • TABLE 153. SIEMENS HEALTHINEERS: KEY EXECUTIVES
  • TABLE 154. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
  • TABLE 155. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS
  • TABLE 156. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
  • TABLE 157. SIEMENS HEALTHINEERS: KEY STRATERGIES
  • TABLE 158. SPACELABS HEALTHCARE: KEY EXECUTIVES
  • TABLE 159. SPACELABS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 160. SPACELABS HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 161. SPACELABS HEALTHCARE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALMEDICAL IMAGE ANALYSIS SOFTWARE MARKET
  • FIGURE 10. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY TYPE, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR INTEGRATED, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR STAND-ALONE, BY COUNTRY 2021-2031(%)
  • FIGURE 13. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY MODALITY, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ULTRASOUND, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR COMBINED MODALITIES, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY APPLICATION, 2021(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ORTHOPEDIC, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DENTAL, BY COUNTRY 2021-2031(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR NEUROLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR CARDIOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR ONCOLOGY, BY COUNTRY 2021-2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 26. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, BY END USER, 2021(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF MEDICAL IMAGE ANALYSIS SOFTWARE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 30. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET BY REGION, 2021
  • FIGURE 31. U.S. MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CANADA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. MEXICO MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. GERMANY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. FRANCE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. UK MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. ITALY MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SPAIN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. REST OF EUROPE MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. CHINA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. JAPAN MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. INDIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 43. AUSTRALIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 44. SOUTH KOREA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 46. BRAZIL MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 47. SAUDI ARABIA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 48. SOUTH AFRICA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 49. REST OF LAMEA MEDICAL IMAGE ANALYSIS SOFTWARE MARKET, 2021-2031 ($MILLION)
  • FIGURE 50. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 51. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 52. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 53. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 54. COMPETITIVE DASHBOARD
  • FIGURE 55. COMPETITIVE HEATMAP: MEDICAL IMAGE ANALYSIS SOFTWARE MARKET
  • FIGURE 56. TOP PLAYER POSITIONING, 2021
  • FIGURE 57. AGFA HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 58. AGFA HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. AGFA HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. CANON MEDICAL SYSTEMS CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. GE HEALTHCARE: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 64. GE HEALTHCARE: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021 ($MILLION)
  • FIGURE 65. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 66. GE HEALTHCARE: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 67. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 68. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 69. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 70. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. KONINKLIJKE PHILIPS N.V. : NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 72. KONINKLIJKE PHILIPS N.V. : RESEARCH & DEVELOPMENT EXPENDITURE, 2019-2021
  • FIGURE 73. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 74. KONINKLIJKE PHILIPS N.V. : REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 75. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 76. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 77. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%)